Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    October 2017
  1. WU QN, Liao YF, Lu YX, Wang Y, et al
    Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Cancer Lett. 2017 Oct 16. pii: S0304-3835(17)30631.
    PubMed     Text format     Abstract available


  2. CHEN J, Li GQ, Zhang L, Tang M, et al
    Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
    Cancer Lett. 2017 Oct 12. pii: S0304-3835(17)30626.
    PubMed     Text format     Abstract available


  3. GUO W, You X, Wang X, Wang L, et al
    A synthetic peptide hijacks the catalytic subunit of class I PI3K to suppress the growth of cancer cells.
    Cancer Lett. 2017;405:1-9.
    PubMed     Text format     Abstract available


    September 2017
  4. LI B, Wang W, Li Z, Chen Z, et al
    MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Cancer Lett. 2017 Sep 28. pii: S0304-3835(17)30596.
    PubMed     Text format     Abstract available


  5. LI Y, Huang S
    Response to Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Sep 26. pii: S0304-3835(17)30553.
    PubMed     Text format    


    August 2017
  6. ZHANG J, Zhu J
    Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Aug 26. pii: S0304-3835(17)30505.
    PubMed     Text format    


  7. MA DH, Li BS, Liu JJ, Xiao YF, et al
    miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
    Cancer Lett. 2017 Aug 24. pii: S0304-3835(17)30504.
    PubMed     Text format     Abstract available


  8. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Text format     Abstract available


  9. NORONHA V, Patil VM, Joshi A, Chougule A, et al
    Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer.
    Cancer Lett. 2017;400:267-275.
    PubMed     Text format     Abstract available


    July 2017
  10. RIBEIRO J, Malta M, Galaghar A, Silva F, et al
    P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Cancer Lett. 2017;404:37-43.
    PubMed     Text format     Abstract available


    June 2017
  11. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Text format     Abstract available


    May 2017
  12. LI Y, Huang S
    Response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 30. pii: S0304-3835(17)30330.
    PubMed     Text format    


  13. SUN Z, Liu J, Zhou Q, Yang S, et al
    Comment on "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 20. pii: S0304-3835(17)30331.
    PubMed     Text format    


    April 2017
  14. GEN Y, Yasui K, Kitaichi T, Iwai N, et al
    ASPP2 suppresses invasion and TGF-beta1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
    Cancer Lett. 2017 Apr 8. pii: S0304-3835(17)30232.
    PubMed     Text format     Abstract available


    March 2017
  15. LI Y, Wu Z, Yuan J, Sun L, et al
    Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
    Cancer Lett. 2017 Mar 4. pii: S0304-3835(17)30152.
    PubMed     Text format     Abstract available


    February 2017
  16. FERREIRA JA, Magalhaes A, Gomes J, Peixoto A, et al
    Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Cancer Lett. 2017;387:32-45.
    PubMed     Text format     Abstract available


  17. XU L, Zhou R, Yuan L, Wang S, et al
    IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
    Cancer Lett. 2017 Feb 18. pii: S0304-3835(17)30122.
    PubMed     Text format     Abstract available


  18. WU H, Liu S, Gong J, Liu J, et al
    VCPA, a novel synthetic derivative of alpha-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30107.
    PubMed     Text format     Abstract available


    January 2017
  19. TSAI MM, Wang CS, Tsai CY, Chen CY, et al
    Corrigendum to "MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer" [Cancer Lett 351 (2014) 222-231].
    Cancer Lett. 2017 Jan 27. pii: S0304-3835(17)30071.
    PubMed     Text format    


    December 2016
  20. MI Y, Zhang D, Jiang W, Weng J, et al
    miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30803.
    PubMed     Text format     Abstract available


  21. CHEN J, Li Y, Zheng Q, Bao C, et al
    Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer.
    Cancer Lett. 2016;388:208-219.
    PubMed     Text format     Abstract available


    November 2016
  22. YUAN W, Liu B, Wang X, Li T, et al
    CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
    Cancer Lett. 2016 Nov 17. pii: S0304-3835(16)30703.
    PubMed     Text format     Abstract available


  23. LI R, Liu B, Gao J
    The application of nanoparticles in diagnosis and theranostics of gastric cancer.
    Cancer Lett. 2016 Nov 11. pii: S0304-3835(16)30663.
    PubMed     Text format     Abstract available


  24. WANG Z, Wang Z, Li G, Wu H, et al
    CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin beta1/FAK/AKT signaling.
    Cancer Lett. 2016;385:28-38.
    PubMed     Text format     Abstract available


    October 2016
  25. HWANG DW, Bang NY, Ito K, Ha S, et al
    In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30661.
    PubMed     Text format     Abstract available


  26. PENG Y, Zhang X, Ma Q, Yan R, et al
    MiRNA-194 activates the Wnt/beta-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30666.
    PubMed     Text format     Abstract available


  27. WANG JB, Wang ZW, Li Y, Huang CQ, et al
    CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of beta-catenin signaling.
    Cancer Lett. 2016 Oct 25. pii: S0304-3835(16)30645.
    PubMed     Text format     Abstract available


    August 2016
  28. KONG Y, Zou S, Yang F, Xu X, et al
    RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.
    Cancer Lett. 2016;381:138-148.
    PubMed     Text format     Abstract available


    July 2016
  29. XIA J, Wang H, Huang H, Sun L, et al
    Elevated orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer.
    Cancer Lett. 2016 Jul 15. pii: S0304-3835(16)30409.
    PubMed     Text format     Abstract available


  30. DU Y, Yu J, Du L, Tang J, et al
    Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin.
    Cancer Lett. 2016;376:240-8.
    PubMed     Text format     Abstract available


    June 2016
  31. HOU J, Wang T, Xie Q, Deng W, et al
    N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65.
    Cancer Lett. 2016;376:22-33.
    PubMed     Text format     Abstract available


  32. WANG Q, Zhang X, Shen E, Gao J, et al
    The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer.
    Cancer Lett. 2016 Jun 15. pii: S0304-3835(16)30365.
    PubMed     Text format     Abstract available


    May 2016
  33. TAKAHASHI K, Tanaka M, Yashiro M, Matsumoto M, et al
    Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells.
    Cancer Lett. 2016 May 6. pii: S0304-3835(16)30289.
    PubMed     Text format     Abstract available


    March 2016
  34. LIU JJ, Liu JY, Chen J, Wu YX, et al
    Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients.
    Cancer Lett. 2016 Mar 24. pii: S0304-3835(16)30195.
    PubMed     Text format     Abstract available


  35. ZHANG H, Bai M, Deng T, Liu R, et al
    Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.
    Cancer Lett. 2016 Mar 18. pii: S0304-3835(16)30176.
    PubMed     Text format     Abstract available


  36. ZOU P, Xia Y, Ji J, Chen W, et al
    Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
    Cancer Lett. 2016 Mar 7. pii: S0304-3835(16)30136.
    PubMed     Text format     Abstract available


  37. JIA X, Cui J, Meng X, Xing L, et al
    Malignant transformation of human gastric epithelium cells via reactive oxygen species production and Wnt/beta-catenin pathway activation following 40-week exposure to ochratoxin A.
    Cancer Lett. 2016;372:36-47.
    PubMed     Text format     Abstract available


    February 2016
  38. YONG X, Tang B, Xiao YF, Xie R, et al
    Helicobacter pylori upregulates Nanog and Oct4 via Wnt/beta-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.
    Cancer Lett. 2016 Feb 29. pii: S0304-3835(16)30100.
    PubMed     Text format     Abstract available


  39. GARAY J, Piazuelo MB, Majumdar S, Li L, et al
    The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice.
    Cancer Lett. 2016;371:90-8.
    PubMed     Text format     Abstract available


    January 2016
  40. ROVIELLO G, Ravelli A, Polom K, Petrioli R, et al
    Apatinib: a novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer.
    Cancer Lett. 2016 Jan 18. pii: S0304-3835(16)00026.
    PubMed     Text format     Abstract available


    December 2015
  41. SHAN F, Miao R, Xue K, Li Z, et al
    Controlling angiogenesis in gastric cancer: a systematic review of anti-angiogenic trials.
    Cancer Lett. 2015 Dec 24. pii: S0304-3835(15)00774.
    PubMed     Text format     Abstract available


    November 2015
  42. YANG Z, Guo X, Li G, Shi Y, et al
    Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Cancer Lett. 2015 Nov 11. pii: S0304-3835(15)00685.
    PubMed     Text format     Abstract available


    October 2015
  43. LI H, Wang Z, Zhang W, Qian K, et al
    Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
    Cancer Lett. 2015 Oct 9. pii: S0304-3835(15)00623.
    PubMed     Text format     Abstract available


    September 2015
  44. SHI DB, Wang YW, Xing AY, Gao JW, et al
    FC/EBPalpha-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer.
    Cancer Lett. 2015 Sep 23. pii: S0304-3835(15)00583.
    PubMed     Text format     Abstract available


    August 2015
  45. LIU Y, Zhang X, Zhang Y, Hu Z, et al
    Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer.
    Cancer Lett. 2015 Aug 11. pii: S0304-3835(15)00516.
    PubMed     Text format     Abstract available


  46. XU M, Gong A, Yang H, George SK, et al
    Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44/Musashi-1 gastric cancer stem cells.
    Cancer Lett. 2015 Aug 11. pii: S0304-3835(15)00534.
    PubMed     Text format     Abstract available


    June 2015
  47. MARANO L, Chiari R, Fabozzi A, De Vita F, et al
    c-Met targeting in advanced gastric cancer: An open challenge.
    Cancer Lett. 2015 Jun 3. pii: S0304-3835(15)00378.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: